Effects of Low Lactose Milk Containing GOS on Digestive Response in Healthy Chinese Adults
MilkRI
Assessing the Effects of Low Lactose Milk Containing GOS (Galactooligosaccharides) on Digestive Response in Healthy Chinese Adults
1 other identifier
interventional
24
1 country
1
Brief Summary
We are aiming to assess the effects of low lactose milk containing galactooligosaccharides (GOS) on digestive response in healthy Chinese adults in comparison with a matching milk containing lactose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2024
CompletedStudy Start
First participant enrolled
August 20, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedNovember 24, 2025
November 1, 2025
8 months
August 15, 2024
November 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Small bowel water content
Small bowel water content measured via MRI and calculated using the trapezoidal rule (mL\*min) at 45 minutes of interval
0-315 minutes after investigational product (IP) or comparator product (CP) intake
Gut motility
Maximum gut motility after product consumption (arbitrary unit) assessed via MRI performed every 45 min
0-315 minutes after IP or CP intake
Secondary Outcomes (11)
Gastric emptying
0-315 minutes after IP or CP intake
Retention rate of gastric content volumes
0-315 minutes after IP or CP intake
Oro-caecal transit
0-315 minutes after IP or CP intake
H2 levels
0-315 minutes after IP or CP intake
Colonic volume
0-315 minutes after IP or CP intake
- +6 more secondary outcomes
Other Outcomes (1)
Appetite
0-315 minutes after IP or CP intake
Study Arms (2)
Arm 1
OTHERVisit 1: Comparator Product; Visit 2: Investigational Product
Arm 2
OTHERVisit 1: Investigational Product; Visit 2: Comparator Product
Interventions
1 single dose of IP consisting in 400 mL of milk with low lactose content and GOS.
Eligibility Criteria
You may qualify if:
- Participants declare that they are of Chinese ethnicity as well as both of their biological parents
- Women and men aged between 18 and 60 years
- Body mass index (BMI ≥ 18.5 \& \<30 kg/m2)
- Healthy: no medical conditions or previous gastrointestinal surgery which might affect study measurements (as declared by the participant)
- Able to understand and to sign written informed consent prior to study entry
- Informed consent signed
- Meets all the criteria for MRI Scan
- Can read and speak English
You may not qualify if:
- Medically diagnosed milk allergy
- Subjects not willing and/or not able to comply with scheduled visits and the requirements of the study protocol
- Diagnosed with any gastrointestinal disorders
- History of claustrophobia
- Pregnant (defined by pregnancy test) or breast feeding
- History or current psychiatric illness
- History or current neurological condition (e.g. epilepsy)
- Consumption of \> 21 alcoholic drinks in a typical week (one serving is 0.4 dl of spirits, 1 dl of wine, or 3 dl of beer as declared by participant)
- Currently smoking (as declared by participant)
- Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance
- Antibiotic use within the 4 weeks preceding the intervention
- Probiotic \& prebiotics use within the 2 weeks preceding the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Société des Produits Nestlé (SPN)lead
- University of Nottinghamcollaborator
Study Sites (1)
University of Nottingham
Nottingham, United Kingdom
Study Officials
- STUDY DIRECTOR
Irma Silva Zolezzi
Societé des Produits Nestlé SA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Single coding
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2024
First Posted
September 19, 2024
Study Start
August 20, 2024
Primary Completion
April 21, 2025
Study Completion
June 30, 2025
Last Updated
November 24, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share